Clinical trials
Connective Tissue Diseases trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 3 |
| Active, not recruiting | 3 |
| Unknown status | 1 |
| Suspended | 1 |
| Terminated | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| GlaxoSmithKline | 2 |
| United Therapeutics | 2 |
| AbbVie | 1 |
| AstraZeneca | 1 |
| Beeline Medicines Corporation | 1 |
| Eli Lilly and Company | 1 |
| Emerald Health Pharmaceuticals | 1 |
| Endo USA Inc., a Keenova Therapeutics Company | 1 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Connective Tissue Diseases | 15 |
| Autoimmune Diseases | 6 |
| Immune System Diseases | 5 |
| Lung Diseases, Interstitial | 4 |
| Lupus Erythematosus, Systemic | 4 |
| Scleroderma, Diffuse | 4 |
| Arthritis, Rheumatoid | 3 |
| Lung Diseases | 3 |
| Musculoskeletal Diseases | 3 |
| Arthritis | 2 |
Trials
Showing 51 to 15 of 15. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.